Showing 1-10 out of 51
Page 1 of 612345...»Last »
Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activationClermont AC, Murugesan N, Edwards HJ, Lee DK, Bayliss NP, Duckworth EJ, Pethen SJ, Hampton SL, Gailani D, Feener EP
Frontiers in Pharmacology
Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real-World ACARE SurveyMaurer M, Magerl M, Riedl MA, Danese S, Ulloa J, Desai V, Audhya PK
UCARE 2023
Diagnosing Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real World ACARE SurveyRiedl MA, Magerl M, Maurer M, Danese S, Ulloa J, Desai V, Audhya PK
UCARE 2023
Refining Prevalence Estimates of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH)Magerl M , Riedl MA, Maurer M, Danese S, Ulloa J, Desai V, Audhya PK
UCARE 2023
Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated BarriersSavic S, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya PK, Yong P
BSI-CIPN 2023
Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) AttacksEl-Shanawany T, Yong P, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya PK, Savic S
BSI-CIPN 2023
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacksTachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK
Allergy and Asthma Proceedings
Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with ThemGeng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C
ACAAI 2023
Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real-World ACARE SurveyMarcus Maurer M, Markus Magerl M, Marc A, Riedl MA, Sherry Danese S, Julie Ulloa J, Vibha Desai V, Paul K, Audhya PK
ACAAI 2023
Treatment Patterns Among Individuals with Hereditary Angioedema in the United StatesTachdjian R, Chang R, DerSarkissian M, Cribbs KA, Lahue BJ, Czado S, Desai V
ACAAI 2023